Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Abeona Therapeutics Inc (NASDAQ: ABEO)

 
ABEO Technical Analysis
4
As on 9th Jun 2023 ABEO STOCK Price closed @ 4.25 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.92 & Strong Buy for SHORT-TERM with Stoploss of 0.28 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ABEOSTOCK Price

Open 4.38 Change Price %
High 4.38 1 Day -0.04 -0.93
Low 3.79 1 Week 1.16 37.54
Close 4.25 1 Month 1.12 35.78
Volume 623100 1 Year 3.94 1270.97
52 Week High 5.65 | 52 Week Low 0.14
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ABEO
Daily Charts		 ABEO
Intraday Charts		 Whats New @
Bazaartrend		 ABEO
Free Analysis
 
ABEO Important Levels Intraday
RESISTANCE5.39
RESISTANCE5.02
RESISTANCE4.80
RESISTANCE4.57
SUPPORT3.93
SUPPORT3.70
SUPPORT3.48
SUPPORT3.11
 
ABEO Forecast April 2024
Share
4th UP Forecast4.5
3rd UP Forecast4.42
2nd UP Forecast4.37
1st UP Forecast4.32
1st DOWN Forecast4.18
2nd DOWN Forecast4.13
3rd DOWN Forecast4.08
4th DOWN Forecast4
 
ABEO Weekly Forecast
4th UP Forecast4.42
3rd UP Forecast4.37
2nd UP Forecast4.33
1st UP Forecast4.30
1st DOWN Forecast4.20
2nd DOWN Forecast4.17
3rd DOWN Forecast4.13
4th DOWN Forecast4.08
 
ABEO Forecast2024
4th UP Forecast15.81
3rd UP Forecast12.1
2nd UP Forecast9.81
1st UP Forecast7.52
1st DOWN Forecast0.98
2nd DOWN Forecast-1.31
3rd DOWN Forecast-3.6
4th DOWN Forecast-7.31
 
 
ABEO Other Details
Segment EQ
Market Capital 82003992.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ABEO Address
ABEO
 
ABEO Latest News
 
Your Comments and Response on Abeona Therapeutics Inc
 
ABEO Business Profile
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-201 to treat CLN3 disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in New York, New York. Address: 1330 Avenue of the Americas, New York, NY, United States, 10019
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service